XML 30 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Note 13 - Income Taxes
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

NOTE 13 Income Taxes

Income tax expense for the years ended December 31, 2022 and 2021 is as follows:

 

(Dollars in thousands)

 

2022

  

2021

 

Current:

        

Federal

 $2,123   3,234 

State

  1,000   1,519 

Total current

  3,123   4,753 

Deferred:

        

Federal

  2   410 

State

  101   202 

Total deferred

  103   612 

Income tax expense

 $3,226   5,365 
         

 

The reasons for the difference between the expected income tax expense utilizing the federal corporate tax rate of 21% and the actual income tax expense are as follows:

 

(Dollars in thousands)

 

2022

  

2021

 

Expected federal income tax expense

 $2,367   3,975 

Items affecting federal income tax:

        

State income taxes, net of federal income tax deduction

  899   1,350 

Other, net

  (40)  40 

Income tax expense

 $3,226   5,365 
         

 

The tax effects of temporary differences that give rise to the deferred tax assets and deferred tax liabilities are as follows at December 31:

 

(Dollars in thousands)

 

2022

  

2021

 

Deferred tax assets:

        

Allowances for loan losses

 $2,899   2,610 

Deferred compensation costs

  120   143 

Deferred ESOP loan asset

  361   399 

Non-accruing loan interest

  179   96 

Net unrealized loss on securities available for sale

  6,539   618 

Other

  110   679 

Total gross deferred tax assets

  10,208   4,545 
         

Deferred tax liabilities:

        

Deferred loan costs

  243   272 

Premises and equipment basis difference

  618   669 

Originated mortgage servicing rights

  843   923 

Other

  157   152 

Total gross deferred tax liabilities

  1,861   2,016 

Net deferred tax assets

 $8,347   2,529 
         

 

The Company has no federal or state net operating loss carryforwards at December 31, 2022.

 

Retained earnings at December 31, 2022 included approximately $8.8 million for which no provision for income taxes was made. This amount represents allocations of income to bad debt deductions for tax purposes. Reduction of amounts so allocated for purposes other than absorbing losses will create income for tax purposes, which will be subject to the then-current corporate income tax rate.

 

The Company considers the determination of the deferred tax asset amount and the need for any valuation reserve to be a critical accounting policy that requires significant judgment. The Company has, in its judgment, made reasonable assumptions and considered both positive and negative evidence relating to the ultimate realization of deferred tax assets. Positive evidence includes the cumulative net income generated over the prior three-year period and the probability that taxable income will be generated in future periods. The Company could not currently identify any negative evidence. Based upon this evaluation, the Company determined that no valuation allowance was required with respect to the net deferred tax assets at December 31, 2022 and 2021.